RGCC- Can provide not only a “circulating tumor cell count” which is important to know AND to monitor your progress, but also, it provides information on what chemo drugs are most effective at killing YOUR body’s cancer cells, how different substances slowed the cancer cell growth, how those substances positively affected your immune system and MORE!
According to the company.. “This test provides information about the effect of specific anti-cancer drugs, targeted therapies and natural treatments on the cancer cells in an individual patient. The test combines a molecular and a cellular approach by incorporating two procedures: epigenetic analysis and viability assays.
Onconomics Plus RGCC
Onconomics Plus RGCC is based on three methods: testing for the direct effect of an anti-cancer treatment, stimulating the immune system and inhibiting proliferative signals in the cancer cells that stimulate them to grow.” (quote from RGCC-group.com)
This test is considered to be a “liquid biopsy test”. Currently is it used to determine cancer caused gene expression changes in breast, liver, lung and colon cancers with 20 other different cancers to be approved in the future. That means that cancer cells turn on and off genes so that they can grow easily. When we see those changes- we know to do additional testing. Again, it does all that AND it is only a blood test!
This stands for Anti-Malignan Antibody in Serum, which is a “well-defined antigen whose levels rise early in the course of the cancer disease process. In some cases, the AMAS test has been positive (elevated) early, 1 to 19 months before clinical detection.” This test is used to help determine IF there is cancer and for progress monitoring and all it takes is just one vial of blood!
Cells become cancerous when they stop using oxygen to make energy and use an oxygen free fermentation process for fuel instead. At the same time, the nagalase enzyme is released at a proportional amount to “drug” the macrophage portion of the immune system. In a healthy body, macrophages search out dying, diseased or injured cells in the body and they consume them! By “coating” themselves and disabling the immune system, cancer cells go unchecked and multiply. This test tells us whether and how much nagalase enzyme is in circulation which lets us know if there is cancer activity in the body.
When you eat foods that you are sensitive to, your body becomes inflamed. Inflammation is considered to be at the root of all chronic illness as well as many respiratory, neurologic, skin and digestive issues. ALCAT measures immune cell response to specific foods, additives and other dietary items to help with weight management, health optimization and performance as well as decrease inflammation!
Human Chorionic Gonadotropin test: A highly accurate urine test that measures a hormone that increases in pregnant women and people with cancer- both growing “something other than themselves” inside them.
Human chorionic gonadotropin, or HCG, can be checked through both the urine and blood. Lab tests to check HCG levels are typically run to verify pregnancy. Yet the presence of HCG in the body can also be a marker for certain types of malignant tumors, according to the American Cancer Society. A positive HCG test can be indicative of several cancers including certain sex-specific forms of the disease.
Elevated levels of the hormone HCG, whether in regard to pregnancy or not, inform you that “something besides you is growing in you”. When there is no chance of pregnancy, it can be a very important tool that can alert us to a current disease state.
Ovarian and testicular cancers are examples of cancers that may produce HCG, according to the American Cancer Society. Checking HCG levels not only aids in diagnosis but can also be used to evaluate the efficacy of treatment of these malignancies. HCG tests are also used to diagnose choriocarcinoma, a rare form of cancer in women.
A positive HCG test outside of pregnancy can also be a sign of other cancers that affect both sexes. A case study published in the journal “Lung Cancer” in September 2008 told the story of a young woman who’d received a positive pregnancy test. The patient had worsening symptoms associated with pneumonia, however, and it was only later discovered that she had HCG-secreting lung tumors. HCG levels were also found to be a strong indicator in determining pancreatic cancer prognoses, according to a 2004 study in the journal “Oncology.” The Stanford Medicine Cancer Center reports that HCG may also be a marker of stomach and liver cancers as well.
or complete blood count, a metabolic panel, to determine organ function limitations, and a G6PD which is used to determine candidacy for intravenous vitamin C therapy may also be needed to properly direct your treatment.